Relive the excitement of the Patriots’ path to their fourth Super Bowl Championship with “Pumped,” a special commemorative book from The Boston Globe.

Mass. Movers

HeartWare’s big gain is erased

A patient undergoes a heart transplant.

Seattle Times via AP/File 2012

A patient undergoes a heart transplant.

The stock’s swings were almost enough to quicken the pulse: The FDA on Tuesday approved a heart pump from HeartWare International Inc., of Framingham, for patients awaiting a heart transplant, and the shares rose 9 percent, the most in seven months. But on Wednesday, the stock fell nearly 9 percent. Similar ventricular assist devices have been approved previously, but HeartWare’s device is smaller and may be easier to implant. The pumps are intended to take over for a failing heart, extending patients’ lives or gaining time to find a heart donor.

Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking. Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com